RT Journal Article
SR Electronic
T1 Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation.
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1615
OP 1618
VO 29
IS 8
A1 Ole Kudsk Jensen
A1 Claus Rasmussen
A1 Frank Mollerup
A1 Peder Bjerg Christensen
A1 Henrik Hansen
A1 Suzanne Ekelund
A1 Ane Marie Thulstrup
YR 2002
UL http://www.jrheum.org/content/29/8/1615.abstract
AB OBJECTIVE: To examine the effect of methotrexate (MTX) and folic acid supplementation on the homocysteine level in patients with rheumatoid arthritis (RA). METHODS: A cross sectional study was performed in 81 patients with RA, comprising a standardized clinical interview, an examination, and a blood specimen test. RESULTS: P-homocysteine tended to be lower in 41 patients receiving MTX, compared with 40 patients not receiving MTX. Of the MTX treated patients, 76% received folic acid supplementation. Multivariate analysis revealed a statistically significant association between P-homocysteine and P-creatinine (p < 0.001), and disease activity/progression measured by the Health Assessment Questionnaire score (p < 0.001). There was a tendency to negative association between P-homocys-teine and folic acid supplementation. CONCLUSION: P-homocysteine in patients with RA receiving MTX and folic acid supplementation did not differ significantly from P-homocysteine in RA patients receiving other types of treatment.